Article citationsMore>>

Yamaguchi, M., Honda, R., Erdenebaatar, C., Monsur, M., Honda, T., Sakaguchi, I., et al. (2017) Treatment of Cervical Pregnancy with Ultrasound-Guided Local Methotrexate Injection. Ultrasound in Obstetrics & Gynecology, 50, 781-787.
https://doi.org/10.1002/uog.17384

has been cited by the following article:

• TITLE: Cervical Pregnancy in a Primigravida Patient without Risk Factors: A Case Report

  AUTHORS: Dieudonné Sengeyi Mushengezi Amani, Eloge Ilunga-Mbaya, Francis Ebola Iyawa, Berry Kinkenda Nsiangangu

  KEYWORDS: Cervical Pregnancy, Risk Factors, Hemorrhage, Methotrexate

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.10 No.6, June 11, 2020

  ABSTRACT: Cervical pregnancy is defined as the implantation of the egg below of the internal cervical orifice, and remains a rare clinical entity which affects on average 1 out of 20,000 pregnancies worldwide. Its hemorrhagic complications are life-threatening in case of late diagnosis. It occurs mainly on a history of curettage or caesarian which are the most recognized risk factors. The objective pursued here is to discuss the possibility of the occurrence of this rare clinical entity in a primigravida without risk factors and the different therapeutic possibilities according to the technical platforms. Authors report a case of cervical pregnancy at 6 weeks’ gestation occurring in a primigravida without risk factors who consulted at University clinics of Kinshasa (UCK) for a genital hemorrhage chart. The diagnosis was made using ultrasound and treatment provided by curettage followed by the placement of an intra-cervical foley tube for hemostatic purposes. Given its high mortality, the diagnosis must be early even in pregnant women without obvious risk factors. The diversity of therapeutic means gives practitioners a choice depending on the technical platform.